In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2005 | 29 | No |
Popular Name: Spironolactone Spironolactone
17-Hydroxy-7-alpha-mercapto-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid-gamma-lactone-7-acetate
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
52-01-7; Aldactone (TN); D00443; Spironolactone (JP16/USP/INN)
52-01-7; C07310; Spironolactone
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
betapharm Brand of Spironolactone
Cardel Brand of Spironolactone
CPD000471892; SAM002264648; Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
espironolactona; spironolactone; spironolactonum
Generosan Brand of Spironolactone
Hormosan Brand of Spironolactone
Jenapharm Brand of Spironolactone
Mayoly-Spindler Brand of Spironolactone
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
Novopharm Brand of Spironolactone
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Searle Brand of Spironolactone
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spironolactone; spironolattone
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.03 | 11.84 | -16.36 | 0 | 4 | 0 | 60 | 416.583 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.98e-03 g/l | DrugBank-approved |
Mp [°C] | 198 - 207 | Acros Organics |
MP | 207-208 °C(lit.) | Indofine |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Target | Androgen Receptor | Selleck Chemicals |
Indications | antihypertensive | KeyOrganics Bioactives |
Therapy | diuretic | SMDC Pharmakon |
therap | diuretic, aldosterone antagonist | MicroSource Spectrum |
PUBCHEM_PATENT_ID | EP0005057A1; EP0008950A2; EP0009657A1; EP0011246A1; EP0011282A1; EP0014966A1; EP0019690A1; EP0020941A1; EP0027192A1; EP0027759A1; EP0028525A2; EP0031242A1; EP0031591A1; EP0032623A2; EP0033660A1; EP0035396A2; EP0035856A2; EP0039190A1; EP0040798A2; EP004814 | IBM Patent Data |
Patent Database Links | EP0795327; EP1514877; EP1541175; EP1553091; EP1681051; EP1717226; EP1741713; EP1767534; EP1785144; EP1842543; EP1844774; EP1862181; EP1884513; EP1894567; EP1932529; EP1972336; GB2264710; US2004072880; US2004106833; US2005009870; US2005014786; US2005019280 | ChEBI |
H phrase | H302: Harmful if swallowed | Acros Organics |
H phrase | H302: Harmful if swallowed; H360F: May damage fertility | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : S-1066 | NIH Clinical Collection via PubChem |
P phrase | P201: Obtain special instructions before use | Acros Organics |
P phrase | P201: Obtain special instructions before use; P308 + P313: IF exposed or concerned: Get medical advice/attention; P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell | Acros Organics |
R phrase | R60: May impair fertility. | Acros Organics |
S phrase | S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). | Acros Organics |
S phrase | S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).; S53: Avoid exposure - obtain special instructions before use. | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: S-1066 | NIH Clinical Collection via PubChem |
Hazard | T: Toxic | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR-2-E | Androgen Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 39 | 0.36 | Binding ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 33 | 0.36 | Binding ≤ 10μM |
MCR-1-E | Mineralocorticoid Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2 | 0.42 | Binding ≤ 10μM |
PRGR-1-E | Progesterone Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 400 | 0.31 | Binding ≤ 10μM |
ANDR-2-E | Androgen Receptor (cluster #2 Of 3), Eukaryotic | Eukaryotes | 523 | 0.30 | Functional ≤ 10μM |
ESR1-2-E | Estrogen Receptor Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 5702 | 0.25 | Functional ≤ 10μM |
GCR-2-E | Glucocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 6920 | 0.25 | Functional ≤ 10μM |
MCR-2-E | Mineralocorticoid Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 13 | 0.38 | Functional ≤ 10μM |
Z50425-4-O | Plasmodium Falciparum (cluster #4 Of 22), Other | Other | 10000 | 0.24 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 39.4 | 0.36 | Binding ≤ 1μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 32.6 | 0.36 | Binding ≤ 1μM |
MCR_HUMAN | P08235 | Mineralocorticoid Receptor, Human | 1.6 | 0.42 | Binding ≤ 1μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 399.7 | 0.31 | Binding ≤ 1μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 39.4 | 0.36 | Binding ≤ 10μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 32.6 | 0.36 | Binding ≤ 10μM |
MCR_HUMAN | P08235 | Mineralocorticoid Receptor, Human | 1.6 | 0.42 | Binding ≤ 10μM |
PRGR_HUMAN | P06401 | Progesterone Receptor, Human | 399.7 | 0.31 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 523 | 0.30 | Functional ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 5702 | 0.25 | Functional ≤ 10μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 6920 | 0.25 | Functional ≤ 10μM |
MCR_HUMAN | P08235 | Mineralocorticoid Receptor, Human | 13 | 0.38 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.24 | Functional ≤ 10μM |
Description | Species |
---|---|
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 |